The effect of probiotics on indirect bilirubin levels

The effect of probiotics on indirect bilirubin levels in neonates with neonatal jaundice in neonates hospitalized to Ayatollah Mousavi Hospital in Zanjan

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180311039048N1

Enrollment

120

Registered

2023-12-23

Start date

2023-12-22

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Jaundice in babies. Neonatal jaundice, unspecified

Interventions

Intervention 1: Intervention group: For the treatment of newborns, 5 drops of Procid brand probiotic will be used daily, and the medicine will be prescribed for 3 days. Intervention 2: Control group:

Eligibility

Sex/Gender

All

Age

2 Days to 2 Months

Inclusion criteria

Inclusion criteria: 1- Infants suffering from neonatal jaundice who have referred to Mousavi Zanjan Hospital and are indicated for hospitalization. 2- Babies for whom no fetal anomalies were mentioned before birth. 3- Babies whose jaundice is not pathological.

Exclusion criteria

Exclusion criteria: 1- Babies whose jaundice started on the first day 2- Babies whose jaundice is related to biliary atresia 3- The baby's family is not satisfied.

Design outcomes

Primary

Measure	Time frame
The amount of indirect bilirubin that led to hospitalization. Timepoint: The first day of hospitalization, the second day of hospitalization, the third day of hospitalization. Method of measurement: By laboratory kits through blood sampling.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAzam karimi Asl

Zanjan University of Medical Sciences

karimi.aazam@yahoo.com+98 24 3331 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026